Review
GABA agonists and gabapentin for spastic hypertonia
Affiliations
- PMID: 11723868
Item in Clipboard
Review
GABA agonists and gabapentin for spastic hypertonia
Phys Med Rehabil Clin N Am.
2001 Nov.
Abstract
Spasticity is a result of an imbalance between the afferent excitatory and descending inhibitory pathways after central nervous system damage. Its pharmacologic control is believed to result from the antagonism of inhibitory mechanisms (gamma-aminobutyric acid [GABA] or glycine-mediated antagonism of excitatory mechanisms), or both. Because GABA receptor sites are widely present in the central nervous system, it is amenable to pharmacologic manipulation.
Similar articles
-
Pharmacotherapy of spasticity: oral medications and intrathecal baclofen.J Child Neurol. 2001 Jan;16(1):31-6. doi: 10.1177/088307380101600106. J Child Neurol. 2001. PMID: 11225954 Review.
-
Antispasticity medications: uses and limitations of enteral therapy.Am J Phys Med Rehabil. 2004 Oct;83(10 Suppl):S50-8. doi: 10.1097/01.phm.0000141132.48673.fa. Am J Phys Med Rehabil. 2004. PMID: 15448578 Review. No abstract available.
-
A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus.Ann Neurol. 1997 Jun;41(6):818-25. doi: 10.1002/ana.410410620. Ann Neurol. 1997. PMID: 9189045 Clinical Trial.
-
The anticonvulsant, antihyperalgesic agent gabapentin is an agonist at brain gamma-aminobutyric acid type B receptors negatively coupled to voltage-dependent calcium channels.J Pharmacol Exp Ther. 2001 Jul;298(1):15-24. J Pharmacol Exp Ther. 2001. PMID: 11408520
-
A GABA(B) mystery: the search for pharmacologically distinct GABA(B) receptors.Mol Interv. 2001 Oct;1(4):208-18. Mol Interv. 2001. PMID: 14993343 Review.
Cited by
-
Exploring Innovative Approaches for Managing Spinal Cord Injury: A Comprehensive Review of Promising Probiotics and Postbiotics.Probiotics Antimicrob Proteins. 2025 Aug;17(4):2112-2132. doi: 10.1007/s12602-025-10513-6. Epub 2025 Apr 15. Probiotics Antimicrob Proteins. 2025. PMID: 40232596 Review.
-
Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes.Front Neurol. 2022 Jan 13;12:799698. doi: 10.3389/fneur.2021.799698. eCollection 2021. Front Neurol. 2022. PMID: 35095742 Free PMC article. Review.
-
GABAB Receptor Chemistry and Pharmacology: Agonists, Antagonists, and Allosteric Modulators.Curr Top Behav Neurosci. 2022;52:81-118. doi: 10.1007/7854_2021_232. Curr Top Behav Neurosci. 2022. PMID: 34036555 Review.